Importer of Controlled Substances Application: Irvine Labs, Inc., 42104 [2023-13812]
Download as PDF
<![CDATA[
42104
Federal Register / Vol. 88, No. 124 / Thursday, June 29, 2023 / Notices
public hearing in connection with the
review, originally scheduled for April
27, 2023, was cancelled (88 FR 26598,
April 25, 2023).
The Commission made this
determination pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determination in
this review on June 26, 2023. The views
of the Commission are contained in
USITC Publication 5433 (June 2023),
entitled Dioctyl Terephthalate from
South Korea: Investigation No. 731–TA–
1330 (Review).
By order of the Commission.
Issued: June 26, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023–13862 Filed 6–28–23; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1197]
Importer of Controlled Substances
Application: Irvine Labs, Inc.
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Irvine Labs, Inc. has applied
to be registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplementary Information
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 31, 2023. Such persons
may also file a written request for a
hearing on the application on or before
July 31, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
SUMMARY:
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on April 20, 2023, Irvine
Labs, Inc. 7305 Murdy Circle,
Huntington Beach, California 92647–
3533, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s).
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
lotter on DSK11XQN23PROD with NOTICES1
Lysergic acid diethylamide ....................................................................................................................................................
Marihuana Extract .................................................................................................................................................................
Marihuana ..............................................................................................................................................................................
Tetrahydrocannabinols ..........................................................................................................................................................
Mescaline ...............................................................................................................................................................................
Peyote ....................................................................................................................................................................................
Diethyltryptamine ...................................................................................................................................................................
Dimethyltryptamine ................................................................................................................................................................
Psilocybin ...............................................................................................................................................................................
Psilocyn .................................................................................................................................................................................
The company plans to import the bulk
substances to support internal research,
clinical trials, analytical purposes, and
distribution to their customers. In
reference to drug codes 7360
(Marihuana), 7350 (Marihuana Extract),
and 7370 (Tetrahydrocannabinols) the
company plans to import a raw plant
material and extracts. No other activities
for these drug codes are authorized for
this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
VerDate Sep<11>2014
17:43 Jun 28, 2023
Jkt 259001
approved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–13812 Filed 6–28–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF LABOR
Office of Workers’ Compensation
Programs
[OMB Control No. 1240–0021]
Proposed Extension of Existing
Collection; Comment Request
Office of Workers’
Compensation Programs, Labor.
ACTION: Request for public comment.
AGENCY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
7315
7350
7360
7370
7381
7415
7434
7435
7437
7438
Schedule
I
I
I
I
I
I
I
I
I
I
The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a pre-clearance request for
comment to provide the general public
and Federal agencies with an
opportunity to comment on proposed
collections of information in accordance
with the Paperwork Reduction Act of
1995. This request helps to ensure that:
requested data can be provided in the
desired format; reporting burden (time
and financial resources) is minimized;
collection instruments are clearly
understood; and the impact of collection
requirements on respondents can be
properly assessed. Currently, OWCP is
soliciting comments on the information
collection for the Provider Enrollment
Form (PE–1168).
DATES: All comments must be received
on or before August 28, 2023.
SUMMARY:
E:\FR\FM\29JNN1.SGM
29JNN1
]]>Agencies
[Federal Register Volume 88, Number 124 (Thursday, June 29, 2023)]
[Notices]
[Page 42104]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13812]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1197]
Importer of Controlled Substances Application: Irvine Labs, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Irvine Labs, Inc. has applied to be registered as an importer
of basic class(es) of controlled substance(s). Refer to Supplementary
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
July 31, 2023. Such persons may also file a written request for a
hearing on the application on or before July 31, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on April 20, 2023, Irvine Labs, Inc. 7305 Murdy Circle,
Huntington Beach, California 92647-3533, applied to be registered as an
importer of the following basic class(es) of controlled substance(s).
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide........... 7315 I
Marihuana Extract.................... 7350 I
Marihuana............................ 7360 I
Tetrahydrocannabinols................ 7370 I
Mescaline............................ 7381 I
Peyote............................... 7415 I
Diethyltryptamine.................... 7434 I
Dimethyltryptamine................... 7435 I
Psilocybin........................... 7437 I
Psilocyn............................. 7438 I
------------------------------------------------------------------------
The company plans to import the bulk substances to support internal
research, clinical trials, analytical purposes, and distribution to
their customers. In reference to drug codes 7360 (Marihuana), 7350
(Marihuana Extract), and 7370 (Tetrahydrocannabinols) the company plans
to import a raw plant material and extracts. No other activities for
these drug codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-13812 Filed 6-28-23; 8:45 am]
BILLING CODE P
